Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sierra oncology, inc. symbols : GLAXF save search
Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $1.08 -0.92% -0.93% 230K
|
Professional, Scientific, and T...
|
| O: -6.96%
H: 7.9%
C: 3.35%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.51%
H: 0.96%
C: 0.54%
GERN | $3.69 -1.07% -1.08% 8.2M
|
Health Technology
|
| O: -1.05%
H: 2.65%
C: 1.06%
corporation
Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.91%
H: 0.56%
C: -0.5%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 0.03%
H: 0.37%
C: 0.18%
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: 0.08%
H: 1.31%
C: 0.77%
vaccine expected cancer global
Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR
Published: 2022-04-18 (Crawled : 22:00) - prnewswire.com
SAIL | $65.24 -0.03%
|
Technology Services
|
| O: -0.3%
H: 0.14%
C: 0.09%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.52%
H: 0.63%
C: -0.15%
MSP 4 | $35.18 0.51%
|
Technology Services
|
| O: 0.0%
H: 0.29%
C: 0.17%
DHI | $142.19 -2.53% 0.06% 3.4M
|
Consumer Durables
|
| O: 0.35%
H: 3.95%
C: 3.52%
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: -0.36%
IESC | News | $115.44 -0.37% -0.37% 120K
|
Industrial Services
|
| O: 0.68%
H: 1.74%
C: 1.09%
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.57%
H: 2.81%
C: 1.26%
CDK | $54.76 -0.15% 0.07%
|
Commercial Services
|
| O: 0.06%
H: 0.02%
C: -0.04%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.18%
H: 0.36%
C: 0.0%
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
Published: 2022-04-13 (Crawled : 09:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 37.85%
H: 0.9%
C: 0.5%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.